HUP0200549A2 - Apomorfint és szildenafilt tartalmazó készítmények és alkalmazásuk - Google Patents

Apomorfint és szildenafilt tartalmazó készítmények és alkalmazásuk

Info

Publication number
HUP0200549A2
HUP0200549A2 HU0200549A HUP0200549A HUP0200549A2 HU P0200549 A2 HUP0200549 A2 HU P0200549A2 HU 0200549 A HU0200549 A HU 0200549A HU P0200549 A HUP0200549 A HU P0200549A HU P0200549 A2 HUP0200549 A2 HU P0200549A2
Authority
HU
Hungary
Prior art keywords
apomorphine
sildenafil composition
sildenafil
composition
Prior art date
Application number
HU0200549A
Other languages
English (en)
Inventor
Ragab El-Rashidy
Original Assignee
Pentech Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals, Inc. filed Critical Pentech Pharmaceuticals, Inc.
Publication of HUP0200549A2 publication Critical patent/HUP0200549A2/hu
Publication of HUP0200549A3 publication Critical patent/HUP0200549A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0200549A 1999-03-16 2000-03-14 Apomorphine and sildenafil composition and their use HUP0200549A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/270,035 US6087362A (en) 1999-03-16 1999-03-16 Apomorphine and sildenafil composition

Publications (2)

Publication Number Publication Date
HUP0200549A2 true HUP0200549A2 (hu) 2002-07-29
HUP0200549A3 HUP0200549A3 (en) 2004-07-28

Family

ID=23029614

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200549A HUP0200549A3 (en) 1999-03-16 2000-03-14 Apomorphine and sildenafil composition and their use

Country Status (21)

Country Link
US (1) US6087362A (hu)
EP (1) EP1173178B1 (hu)
JP (1) JP2002539163A (hu)
CN (1) CN1350454A (hu)
AT (1) ATE302003T1 (hu)
AU (1) AU3744500A (hu)
BR (1) BR0009016A (hu)
CA (1) CA2367605A1 (hu)
CZ (1) CZ20013344A3 (hu)
DE (1) DE60022021T2 (hu)
DK (1) DK1173178T3 (hu)
ES (1) ES2244418T3 (hu)
HU (1) HUP0200549A3 (hu)
IL (1) IL145487A0 (hu)
MX (1) MXPA01009332A (hu)
NO (1) NO324511B1 (hu)
NZ (1) NZ514464A (hu)
PL (1) PL350313A1 (hu)
PT (1) PT1173178E (hu)
WO (1) WO2000054774A1 (hu)
ZA (1) ZA200107920B (hu)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063719A1 (en) * 1998-08-26 2004-04-01 Queen's University At Kingston Combination therapy using antihypertensive agents and endothelin antagonists
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
NZ524601A (en) * 2000-08-30 2006-04-28 Unimed Pharmaceuticals Inc Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
NZ527113A (en) * 2001-02-08 2005-04-29 Pharmacia Corp Rapid-onset medicament for the treatment of sexual dysfunction
ES2180446B1 (es) * 2001-07-02 2004-01-16 Esteve Labor Dr Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
CN1315835C (zh) * 2001-08-28 2007-05-16 先灵公司 多环鸟嘌呤磷酸二酯酶v抑制剂
US20030114469A1 (en) * 2001-09-27 2003-06-19 Cohen David Saul Combinations
US20030216407A1 (en) * 2002-01-31 2003-11-20 Pfizer Inc. Use of PDE5 inhibitors in the treatment of scarring
US20060004190A1 (en) * 2002-03-19 2006-01-05 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US7037257B1 (en) * 2002-08-22 2006-05-02 Koenig J Frank Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications
TWI330529B (en) * 2003-01-13 2010-09-21 Horphag Res Luxembourg Holding Sa A preparation for improving sperm quality or fertility,a kit comprising the same and uses thereof
GB0304636D0 (en) * 2003-02-28 2003-04-02 Britannia Pharmaceuticals Ltd Pharmaceutical composition for nasal delivery
US7306812B2 (en) * 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
DE10325813B4 (de) 2003-06-06 2007-12-20 Universitätsklinikum Freiburg Prophylaxe und/oder Therapie bei der portalen Hypertonie
SI1750766T1 (sl) * 2004-05-11 2013-11-29 Emotional Brain B.V. Farmacevtske formulacije in njihove uporabe pri zdravljenju spolne disfunkcije pri Ĺľenskah
CN102357248A (zh) * 2004-10-20 2012-02-22 恩多研究公司 单独的性甾体前体或与选择性***受体调节剂联合用于防治绝经后女性的***疾病和病症
ZA200803087B (en) 2005-10-12 2009-11-25 Unimed Pharmaceuticals Llc Improved testosterone gel and method of use
MX2009008511A (es) * 2007-02-12 2010-01-20 Dmi Biosciences Inc Reduccion de efectos secundarios de tramadol.
KR20140054312A (ko) * 2007-02-12 2014-05-08 디엠아이 바이오사이언시스 인코포레이티드 조루 및 발기부전을 동시에 치료하는 방법
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CN101945892B (zh) * 2007-12-26 2017-11-24 生物测试股份公司 用于改进对表达cd138的肿瘤细胞的靶向的方法和试剂
CA2710471C (en) * 2007-12-26 2018-06-05 Biotest Ag Immunoconjugates targeting cd138 and uses thereof
KR101626416B1 (ko) * 2007-12-26 2016-06-01 바이오테스트 아게 Ｃｄ138 표적 물질 및 이의 용도
EP2238169A1 (en) * 2007-12-26 2010-10-13 Biotest AG Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates
US20090246298A1 (en) * 2008-03-31 2009-10-01 Ceola P. Steele Viagra
WO2010070617A1 (en) 2008-12-19 2010-06-24 Shimoda Biotech (Pty) Ltd Inclusion complexes of alpha-cyclodextrin and sildenafil salt
JP2012526079A (ja) * 2009-05-06 2012-10-25 バイオテスト・アクチエンゲゼルシヤフト Ｃｄ１３８を標的とする免疫複合体の使用
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
KR102017009B1 (ko) * 2009-06-12 2019-09-02 선오비온 파마슈티컬스 인코포레이티드 설하 아포모르핀
WO2012000634A1 (de) 2010-06-29 2012-01-05 Georg Bambach Pharmazeutische zusammensetzung zur behandlung von erektiler dysfunktion
TWI462739B (zh) 2010-11-02 2014-12-01 Univ Kaohsiung Medical Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
KR101890317B1 (ko) 2010-12-16 2018-08-22 선오비온 파마슈티컬스 인코포레이티드 설하 필름
CA2858133A1 (en) 2011-12-08 2013-06-13 Biotest Ag Uses of immunoconjugates targeting cd138
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
CA2188385C (en) * 1994-04-22 2000-07-11 Ragab El-Rashidy Dosage forms and method for ameliorating male erectile dysfunction
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
NZ500921A (en) * 1997-05-19 2002-11-26 Zonagen Inc Composition containing a-adrenergic antagonist and a phosphodiesterase inhibitor or a dopaminergic agonist for modulating the human sexual response
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
CN1350454A (zh) 2002-05-22
CA2367605A1 (en) 2000-09-21
DE60022021T2 (de) 2006-06-08
PL350313A1 (en) 2002-12-02
US6087362A (en) 2000-07-11
JP2002539163A (ja) 2002-11-19
NZ514464A (en) 2004-01-30
HUP0200549A3 (en) 2004-07-28
MXPA01009332A (es) 2002-06-21
NO324511B1 (no) 2007-11-05
BR0009016A (pt) 2002-04-16
EP1173178A1 (en) 2002-01-23
ATE302003T1 (de) 2005-09-15
PT1173178E (pt) 2005-11-30
WO2000054774A1 (en) 2000-09-21
EP1173178A4 (en) 2002-09-04
DE60022021D1 (de) 2005-09-22
ES2244418T3 (es) 2005-12-16
EP1173178B1 (en) 2005-08-17
DK1173178T3 (da) 2005-11-07
IL145487A0 (en) 2002-06-30
NO20014519L (no) 2001-10-25
ZA200107920B (en) 2003-03-26
AU3744500A (en) 2000-10-04
CZ20013344A3 (cs) 2002-08-14
NO20014519D0 (no) 2001-09-17

Similar Documents

Publication Publication Date Title
HUP0200549A3 (en) Apomorphine and sildenafil composition and their use
IL190220A0 (en) Novel composition and use
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
ZA200101933B (en) Novel composition and use
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AU1403501A (en) Novel composition and use
IL148953A0 (en) Novel hormonal composition and the use thereof
EG22491A (en) Rest-breaking composition and use thereof
GB9902520D0 (en) Composition
AP2001002273A0 (en) Rescorcinol composition
HUP0303936A3 (en) Novel composition and use
GB9927927D0 (en) Compound composition and use
GB2366984B (en) Composition
GB9911606D0 (en) Composition and use
AU5104101A (en) Composition and use
GB2357714B (en) Composition
EG24062A (en) Novel composition and use
GB9912190D0 (en) Novel composition and use
GB9922474D0 (en) Novel composition and use
GB9927119D0 (en) Novel composition and use
GB9912189D0 (en) Novel composition and use
GB9919000D0 (en) Novel composition and use
GB9912193D0 (en) Novel composition and use
GB9927120D0 (en) Novel composition and use
GB9927121D0 (en) Novel composition and use

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees